Delphia Therapeutics
Mackenzie S. is a Senior Research Associate at Delphia Therapeutics, with previous experience as a Research Associate II at ElevateBio and as a Researcher 1 at the Masonic Cancer Center, University of Minnesota. Prior roles include positions at the University of Minnesota as a Teacher's Assistant and Undergraduate Research Assistant, along with a Disaster Recovery Internship at Fairview Health Services. Mackenzie S. also served in leadership roles as a Junior Guild Leader and Sophomore Guild Leader at the University of Minnesota College of Biological Sciences. Mackenzie S. earned a Bachelor of Science degree in Genetics, Cell Biology, and Development from the University of Minnesota between 2017 and 2020.
This person is not in any teams
Delphia Therapeutics
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.